Welcome to our dedicated page for Perimeter Medical Imaging Ai news (Ticker: PYNKF), a resource for investors and traders seeking the latest updates and insights on Perimeter Medical Imaging Ai stock.
Perimeter Medical Imaging AI Inc (PYNKF) delivers cutting-edge imaging solutions for cancer surgery, specializing in AI-enhanced optical coherence tomography (OCT) systems. This page provides official updates on regulatory milestones, clinical research, and technological advancements shaping surgical oncology.
Investors and medical professionals will discover timely updates about the company’s FDA-cleared S-Series OCT platform, B-Series AI integration progress, and strategic partnerships. Content includes earnings reports, trial outcomes, and educational initiatives demonstrating real-world clinical impact.
Key updates cover surgical margin visualization innovations, regulatory submissions, and peer-reviewed study results. All materials are sourced directly from company filings and verified medical publications to ensure accuracy.
Bookmark this page for consolidated access to Perimeter’s latest developments in AI-driven surgical imaging. Regularly updated to reflect new achievements in precision oncology and operational growth.
Perimeter Medical Imaging AI (TSXV: PINK, OTC: PYNKF, FSE: 4PC) has announced it will report its second quarter 2024 financial and operating results after market close on Wednesday, August 14, 2024. Following the announcement, the company's management will host a webcast and conference call to discuss the results and provide a corporate update.
The conference call is scheduled for 5:00 pm Eastern Time on August 14, 2024. Investors can dial in using the following numbers: 1-800-717-1738 (Canada and the United States) or 1-646-307-1865 (International). The call will also be broadcast live and archived on the company's website under the 'News/Events' section in the Investors area.
Perimeter Medical Imaging AI will host an investor webcast on June 25, 2024, at 2:00 PM ET. The event will feature presentations from CEO Adrian Mendes, CIO Andrew Berkeley, and CFO Sara Brien, focusing on key business areas. Investors can engage in a live Q&A session. To participate, pre-register at the provided link. An archived version will be accessible on the company's website.
Perimeter Medical Imaging AI reported its Q1 2024 financial results, highlighting significant progress in clinical development and commercial expansion.
The company exceeded patient enrollment expectations in its pivotal clinical trial for the B-Series OCT with ImgAssist AI, leading to a decision to expedite full enrollment by early Q4 2024. Three new placements of the S-Series OCT system were completed, boosting market presence.
Financially, operating expenses rose to $4.7 million, but net loss decreased to $2.1 million compared to Q1 2023. Cash and equivalents stood at $10.6 million as of March 31, 2024.
A conference call is scheduled for 5 pm ET to discuss the results and provide further updates.
Perimeter Medical Imaging AI, Inc. (PYNKF) will release its first quarter 2024 financial results on May 14, 2024, followed by a conference call hosted by CEO Adrian Mendes. The call will discuss the results and provide a corporate update. Investors can join the call online or via phone.
FAQ
What is the current stock price of Perimeter Medical Imaging Ai (PYNKF)?
What is the market cap of Perimeter Medical Imaging Ai (PYNKF)?
